LOW GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Drug attack on rare ovarian cancer
Disease control Recruiting nowThis study is testing whether a combination of three medications—avutometinib, defactinib, and letrozole—can effectively treat low-grade serous ovarian cancer. It is for patients who are not candidates for complete initial surgery or who still have measurable disease after surger…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Drug combo trial offers hope for women with recurrent ovarian cancer
Disease control Recruiting nowThis study is testing whether a new combination of two oral drugs (avutometinib and defactinib) works better than current standard treatments for women whose low-grade serous ovarian cancer has returned after prior therapy. The trial will involve about 270 participants worldwide …
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE3 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New hope for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing a new drug called ubamatamab, given alone or with another drug (cemiplimab), for people with recurrent ovarian, fallopian tube, peritoneal, or endometrial cancers. The main goals are to find a safe and effective dose and to see if the treatment can shrink tu…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC